DHG’s health care focus makes it a trusted adviser for private equity
The business of buying and selling health care companies has never been an easy one—add a global pandemic and an economic recession, and it’s no surprise that transactions have become downright difficult. However, private equity professionals do not have to go through the process alone. Trusted advisers can help deal professionals navigate even the most intricate parts of transacting in this highly regulated space. Even more helpful is when a private equity firm can work with a trusted adviser that has in-depth industry knowledge and can be a one-stop resource, versus having to rely on a cadre of partners.
Enter Dixon Hughes Goodman (DHG), a national advisory firm with more than 2,000 professionals including a dedicated team servicing the middle-market private equity industry, with a specialization in the health care sector. “Our expertise in both private equity and health care allows us to offer a unique value proposition to our clients,” says Kevin Locke, managing principal of DHG Healthcare. “We look at the deal from both a private equity perspective and a health care perspective, ensuring a thoughtful and comprehensive approach to the transaction.”